Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Leukemia

• Publication date

  2012-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2012.130PMID 22678168PMCID PMC3645466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications

  2012cited by this paper
• SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

  2012cited by this paper
• Polycomb segment myeloid malignancies.

  2012cited by this paper
• SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.

  2012cited by this paper
• Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.

  2012cited by this paper
• SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

  2012cited by this paper
• Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

  2012cited by this paper
• Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.

  2012cited by this paper
• Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis

  2011cited by this paper
• Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin

  2011cited by this paper
• RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

  2011cited by this paper
• Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

  2011cited by this paper
• Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.

  2011cited by this paper
• SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

  2011cited by this paper
• Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

  2011cited by this paper
• Ring sideroblasts and sideroblastic anemias

  2011cited by this paper
• Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations

  2011cited by this paper
• Biological validation that SF3b is a target of the antitumor macrolide pladienolide

  2011cited by this paper
• Genetic therapies for RNA mis-splicing diseases.

  2011cited by this paper
• Phosphorylation mechanism and structure of serine‐arginine protein kinases

  2011cited by this paper
• Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS

  2011cited by this paper
• SRSF2 is Mutated in 47.2% (77/163) of Chronic Myelomonocytic Leukemia (CMML) and Prognostically Favorable in Cases with Concomitant RUNX1 mutations

  2011cited by this paper
• Mutational Spectrum Analysis of Interesting Correlation and Interrelationship Between RNA Splicing Pathway and Commonly Targeted Genes in Myelodysplastic Syndrome

  2011cited by this paper
• Mechanisms of Defective Hydroxylation of 5-Methylcytosine in MDS Include Pathways Other Than TET2 and IDH1/2

  2011cited by this paper
• Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

  2011cited by this paper
• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  2011cited by this paper
• Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

  2011cited by this paper
• Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

  2010cited by this paper
• The pathobiology of splicing

  2010cited by this paper
• Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

  2010cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Mitochondrial Iron Metabolism and Sideroblastic Anemia

  2009cited by this paper
• Synthetic mRNA splicing modulator compounds with in vivo antitumor activity.

  2009cited by this paper
• Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches

  2009cited by this paper
• Meayamycin inhibits pre–messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells

  2009cited by this paper
• Hematological manifestations of copper deficiency: a retrospective review

  2008cited by this paper
• Evolution of Spliceosomal snRNA Genes in Metazoan Animals

  2008cited by this paper
• Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).

  2007cited by this paper
• Splicing Regulator SC35 Is Essential for Genomic Stability and Cell Proliferation during Mammalian Organogenesis

  2007cited by this paper
• Emerging roles of nuclear protein phosphatases

  2007cited by this paper
• Targeting the spliceosome

  2007cited by this paper
• Comprehensive splice-site analysis using comparative genomics

  2006cited by this paper
• snRNAs as the catalysts of pre-mRNA splicing.

  2005cited by this paper
• Are splicing mutations the most frequent cause of hereditary disease?

  2005cited by this paper
• Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1.

  2005cited by this paper
• Iron trafficking in the mitochondrion: novel pathways revealed by disease.

  2005cited by this paper
• Understanding alternative splicing: towards a cellular code

  2005cited by this paper
• Acetaldehyde Adducts in Blood and Bone Marrow of Patients With Ethanol-Induced Erythrocyte Abnormalities

  2001cited by this paper
• A novel U2 and U11/U12 snRNP protein that associates with the pre‐mRNA branch site

  2001cited by this paper
• Elevated concentration of N-CAM VASE isoforms in schizophrenia.

  2000cited by this paper
• Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

  1999cited by this paper
• Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.

  1998cited by this paper
• Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.

  1998cited by this paper
• Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics.

  1998cited by this paper
• Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics

  1998cited by this paper
• A CTD function linking transcription to splicing.

  1997cited by this paper
• Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer.

  1997cited by this paper
• Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

  1994cited by this paper
• bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

  1993cited by this paper
• Proposals for the classification of the myelodysplastic syndromes

  1982cited by this paper

• The impact of mutational burden, spliceosome and epigenetic regulator mutations on transfusion dependency in dysplastic neoplasms

  2025cites this paper
• Reduced transcriptome analysis in zebrafish uncovers disruptors of spliceosome and ribosome biosynthesis.

  2024cites this paper
• Assessing the Methylation Status of Two Potential Key Factors Involved in Cervical Oncogenesis

  2024cites this paper
• Comprehensive mendelian randomization reveals atrial fibrillation-breast cancer relationship and explores common druggable targets

  2024cites this paper
• Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults

  2024cites this paper
• SF3B1-dependent alternative splicing is critical for maintaining endometrial homeostasis and the establishment of pregnancy

  2023cites this paper
• Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer

  2023cites this paper
• Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

  2023cites this paper
• Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

  2022cites this paper
• Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis

  2022cites this paper
• The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer

  2022cites this paper
• Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms

  2022cites this paper
• SF3B1 Mutations in Hematological Malignancies

  2022cites this paper
• Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer.

  2021cites this paper
• Mutant U2AF1-induced differential alternative splicing causes an oxidative stress in bone marrow stromal cells

  2021cites this paper
• Genetic complexity of chronic myelomonocytic leukemia

  2020cites this paper
• Comparison of SF3B1/DNMT3A Comutations With DNMT3A or SF3B1 Mutation Alone in Myelodysplastic Syndrome and Clonal Cytopenia of Undetermined Significance.

  2020cites this paper
• 伴U2AF1基因突变骨髓增生异常综合征患者临床特征及预后分析

  2020cites this paper
• Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation

  2020cites this paper
• The cellular landscape of mid‐size noncoding RNA

  2019cites this paper
• Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.

  2019cites this paper
• Advances in diagnosis of mastocytosis and hypereosinophilic syndrome☆.

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features

  2019cites this paper
• Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis

  2019cites this paper
• RNA Regulators in Leukemia and Lymphoma.

  2019cites this paper
• Alternative tumour-specific antigens

  2019cites this paper
• Development and Characterisation of an AML1/ETO Murine Bone Marrow Transplantation Leukaemia Model

  2019cites this paper
• Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines

  2019cites this paper
• Differential Functions of Splicing Factors in Breast-Cancer Initiation and Metastasis

  2019cites this paper
• Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping

  2018cites this paper
• SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS

  2018cites this paper
• Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

  2018cites this paper
• Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?

  2018cites this paper
• Mastocytose systémique associée au syndrome myélodysplasique : étude rétrospective du centre de référence nationale des mastocytoses

  2018cites this paper
• Clinical characterization and prognostic impact of SF3B1 and TP53 gene mutations in myelodysplastic syndromes

  2018cites this paper
• Chapter 8 New Insights in Prognosis and Therapy of Chronic Lymphocytic Leukaemia

  2017cites this paper
• Method, Composition, and Kit Useful for Treatment of Alzheimer's Disease

  2017cites this paper
• 118例骨髓增生异常综合征及相关疾病患者RNA剪接体复合物蛋白编码基因SF3B1、U2AF1和SRSF2突变分析

  2017cites this paper
• Fanconi anemia FAN CD2 and FAN CI proteins regulate the nuclear dynamics of splicing factors

  2017cites this paper
• Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors

  2017cites this paper
• SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast

  2017cites this paper
• TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

  2017cites this paper
• Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

  2016cites this paper
• U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.

  2016influential citation
• Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

  2016cites this paper
• Insights into myelodysplastic syndromes from current preclinical models

  2016cites this paper
• Intron and Its Splicing Mechanism and Their Connection with Human Disease

  2016cites this paper
• Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

  2016cites this paper
• Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations

  2016cites this paper
• Recent advances in therapeutic strategies that focus on the regulation of ion channel expression.

  2016cites this paper
• Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes.

  2016cites this paper
• MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses

  2016cites this paper
• Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.

  2016cites this paper
• Comprehensive Gene expression meta-analysis and integrated bioinformatic approaches reveal shared signatures between thrombosis and myeloproliferative disorders

  2016cites this paper
• Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis

  2016influential citation
• A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition

  2015cites this paper
• Molecular identification of the dominant-negative, splicing isoform of the two-pore domain K(+) channel K(2P)5.1 in lymphoid cells and enhancement of its expression by splicing inhibition.

  2015cites this paper
• Molecular pathogenesis of CLL and its evolution

  2015cites this paper
• Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.

  2015cites this paper
• The role of mutations in epigenetic regulators in myeloid malignancies

  2015cites this paper
• Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)

  2015cites this paper
• Chronic Lymphocytic Leukemia at the Genomic Level

  2015cites this paper
• New Insights in Prognosis and Therapy of Chronic Lymphocytic Leukaemia

  2015cites this paper
• The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts

  2015cites this paper
• Molecular basis of mast cell disease.

  2015cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6o ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO

  2015cites this paper
• Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology

  2015cites this paper
• Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance

  2015cites this paper
• SRSF1-Regulated Alternative Splicing in Breast Cancer.

  2015cites this paper
• The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.

  2014cites this paper
• Nowe strategie leczenia zespołów mielodysplastycznych wysokiego ryzyka

  2014cites this paper
• 17265 Healthcare-associatedhepatitisCvirusinfection

  2014cites this paper
• PRPF8 Defects Cause Missplicing in Myeloid Malignancies

  2014cites this paper
• Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

  2014cites this paper
• The impact of SF3B1 mutations in CLL on the DNA-damage response

  2014cites this paper
• Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling.

  2014cites this paper
• Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts

  2014cites this paper
• Epigenetics of myelodysplastic syndromes

  2014cites this paper
• Current and novel therapeutic approaches in myelodysplastic syndromes.

  2014cites this paper
• How we treat higher-risk myelodysplastic syndromes.

  2014cites this paper
• How mRNA is misspliced in acute myelogenous leukemia (AML)?

  2014cites this paper
• Identification of the PKR Nuclear Interactome Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell Division

  2014cites this paper
• Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool

  2014cites this paper
• Molecular Pathogenesis of Myelodysplastic Syndromes

  2014cites this paper
• Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome

  2014cites this paper
• Molecular Genetics of Myelofibrosis and its Associated Disease Phenotypes

  2014cites this paper
• Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts

  2014cites this paper
• SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes

  2014cites this paper
• Alternative splicing of DNA damage response genes and gastrointestinal cancers.

  2014cites this paper
• Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.

  2014cites this paper
• Molecular defects in mastocytosis: KIT and beyond KIT.

  2014cites this paper
• Клиническое значение полноэкзомных исследований миелоидных опухолей методом секвенирования следующего поколения

  2013cites this paper
• Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

  2013cites this paper
• SF3B1 mutations in chronic lymphocytic leukemia.

  2013cites this paper
• Клиническое значение полноэкзомных исследований миелоидных опухолей методом секвенирования следующего поколения

  2013cites this paper
• Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

  2013cites this paper
• Making Use of Aberrant and Nonsense: Aberrant Splicing and Nonsense-Mediated Decay as Targets for Personalized Medicine

  2013cites this paper
• CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing

  2013cites this paper
• The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

  2013cites this paper